CenterBook Partners LP Sells 6,223 Shares of AptarGroup, Inc. $ATR

CenterBook Partners LP lessened its stake in AptarGroup, Inc. (NYSE:ATR) by 70.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 2,617 shares of the industrial products company’s stock after selling 6,223 shares during the period. CenterBook Partners LP’s holdings in AptarGroup were worth $317,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in AptarGroup during the 2nd quarter worth about $768,464,000. Dimensional Fund Advisors LP raised its position in shares of AptarGroup by 15.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,504,473 shares of the industrial products company’s stock worth $189,581,000 after acquiring an additional 203,672 shares in the last quarter. Atlas FRM LLC acquired a new stake in shares of AptarGroup during the 2nd quarter worth about $83,884,000. First Trust Advisors LP lifted its stake in AptarGroup by 42.6% during the first quarter. First Trust Advisors LP now owns 538,554 shares of the industrial products company’s stock worth $67,868,000 after purchasing an additional 160,763 shares during the last quarter. Finally, Bank of America Corp DE lifted its stake in AptarGroup by 7.2% during the first quarter. Bank of America Corp DE now owns 485,718 shares of the industrial products company’s stock worth $61,210,000 after purchasing an additional 32,420 shares during the last quarter. 88.52% of the stock is owned by hedge funds and other institutional investors.

AptarGroup News Summary

Here’s some of the latest news about ATR:

• Positive Sentiment: Zacks Research lifted its FY2026 EPS estimate to $5.53 from $5.46, FY2027 to $5.91 from $5.90, and FY2028 to $6.65 from $6.53. It also raised estimates for several upcoming quarters, including Q4 2026, Q1–Q3 2027 and Q1–Q3 2028. The broad upward revisions could support investor optimism about AptarGroup’s earnings outlook.
• Negative Sentiment: Zacks Research reduced its Q4 2027 EPS forecast to $1.46 from $1.49, a limited offset to the generally higher estimates.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on ATR shares. Deutsche Bank assumed coverage on AptarGroup in a report on Wednesday, October 7th. They issued a “buy” rating and a $150.00 price target for the company. Bank of America reissued a “buy” rating on shares of AptarGroup in a report on Monday, November 2nd. UBS Group assumed coverage on shares of AptarGroup in a research note on Friday, October 9th. They issued a “neutral” rating and a $135.00 price objective for the company. Wells Fargo & Company increased their price objective on AptarGroup from $145.00 to $155.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of AptarGroup in a report on Monday, September 21st. Five research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $164.14.

AptarGroup Trading Up 1.0%

Shares of AptarGroup stock opened at $143.12 on Friday. AptarGroup, Inc. has a 52-week low of $110.95 and a 52-week high of $148.63. The company has a quick ratio of 1.03, a current ratio of 1.50 and a debt-to-equity ratio of 0.39. The company’s 50-day simple moving average is $128.06 and its 200-day simple moving average is $127.94. The firm has a market cap of $9.07 billion, a price-to-earnings ratio of 26.34, a price-to-earnings-growth ratio of 4.13 and a beta of 0.33.

AptarGroup (NYSE:ATR) last posted its quarterly earnings results on Thursday, October 29th. The industrial products company reported $1.52 EPS for the quarter, beating the consensus estimate of $1.47 by $0.05. AptarGroup had a return on equity of 13.11% and a net margin of 6.69%. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $980.76 million. During the same period last year, the firm earned $1.62 EPS. The company’s quarterly revenue was up 6.0% compared to the same quarter last year. As a group, equities research analysts anticipate that AptarGroup, Inc. will post 5.56 earnings per share for the current year.

AptarGroup Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 3rd. Shareholders of record on Thursday, November 12th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Thursday, November 12th. This is an increase from AptarGroup’s previous quarterly dividend of $0.48. AptarGroup’s payout ratio is presently 48.54%.

Insiders Place Their Bets

In related news, CEO Gael Touya sold 3,740 shares of the firm’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $133.76, for a total value of $500,262.40. Following the completion of the sale, the chief executive officer owned 29,102 shares in the company, valued at $3,892,683.52. This trade represents a 11.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Shiela Vinczeller sold 765 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $130.37, for a total transaction of $99,733.05. Following the completion of the sale, the insider owned 26,313 shares of the company’s stock, valued at $3,430,425.81. This trade represents a 2.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.73% of the company’s stock.

About AptarGroup

AptarGroup is a global provider of dispensing, packaging and drug-delivery solutions. Its products include pumps, aerosol valves, sprayers, closures and other components used to package and dispense products. The company serves customers in the pharmaceutical, beauty, personal care, food and beverage markets. Its pharmaceutical offerings include systems and components for delivering medicines through nasal, inhaled, ophthalmic and injectable applications, while its packaging solutions help consumer brands dispense and protect products.